Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Albert Labs' Graeme McFarlane shares background & more on their Real World Evidence (RWE) approach

Albert Labs' Graeme McFarlane shares background & more on their Real World Evidence (RWE) approach

Albert Labs Chief Commercial Officer Graeme Mcfarlane joins Proactive London to discuss his experience in the sector with 30 year background in the pharmaceutical industry.

He has held top positions in at Astra Zeneca, GlaxoSmithKline and Bristol Myers. His work at Albert Labs is focused on improving patient access to psychedelic assisted therapies through accelerated regulatory approval pathways across the UK & Europe.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK